Norris Medicines Ltd
NSE: BSE: 524414
₹14.49
(-3.40%)
Wed, 18 Mar 2026, 09:52 am
Market Cap0
PE Ratio0
Dividend0
Health Technology
Pharmaceuticals: Major
24.5KCompany History
1990
- Norris Medicines Limited was established as a private limited company in the state of Maharashtra.
1991
- The company commenced commercial operations with the commissioning of the formulations unit.
1992
- The company launched its Ethical Division and was converted into a public limited company.
1994
- The company received a WHO cGMP certificate.
1995
- The company underwent major expansions.
1996
- The company started exporting to European, Middle East, Far East, and African countries.
2000
- The company issued 1,80,00,000 equity shares on a preferential/private placement basis to PHC Holdings Ltd. and Positive Healthcare (Asia) Ltd.
2006
- The company launched diabetic and cardiac products.
2007
- The company launched a dental product range.
2012
- The company launched a new molecule Tolperisone with Paracetamol tablet.
2013
- The company extended its anti-malarial range with Artemether Lumefantrine tablet and dry syrup.
Open Your Free Demat Account Now!
Facebook
Twitter
Instagram
LinkedIn
Youtube
Calculators
Popular Calculators
Group Stocks
Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800